DIPROSALIC

This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Malta, Netherlands, Poland, Romania, United Kingdom, South Africa

Active ingredients

The drug DIPROSALIC contains a combination of these active pharmaceutical ingredients (APIs):

1 Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

2 Salicylic acid UNII O414PZ4LPZ - SALICYLIC ACID

Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. Read about Salicylic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DIPROSALIC Ointment	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07XC01	Betamethasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XC Corticosteroids, potent, other combinations
Discover more medicines within D07XC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 540917050029217, 540917050029317, 540917060031117
Country: CA	Health Products and Food Branch	Identifier(s): 00578436
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 367310813
Country: EE	Ravimiamet	Identifier(s): 1006041, 1006074, 1062403, 1062425, 1062436, 1734713, 1865123, 1880805, 1880816
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 57463
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 082040, 418673
Country: FR	Base de données publique des médicaments	Identifier(s): 64435022, 66707065
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138669, 138671, 143208, 143211, 161591, 161697, 182527, 19266, 19990, 19992
Country: HK	Department of Health Drug Office	Identifier(s): 23072
Country: IE	Health Products Regulatory Authority	Identifier(s): 21474
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1244, 1245
Country: MT	Medicines Authority	Identifier(s): AA565/11102, AA565/11105
Country: NL	Z-Index G-Standaard	Identifier(s): 12331600, 12360449
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 16861
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100019516, 100019522, 100257612, 100258534, 100258729, 100265132, 100266077, 100269383, 100326141, 100326566, 100338859, 100345486, 100352760, 100359666, 100413532, 100422778, 100425765, 100440109, 100443770, 100468906
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68209001, W68210001
Country: ZA	Health Products Regulatory Authority	Identifier(s): H/13.4.1/32, L/13.4.1/66